Detalles de la búsqueda
1.
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients.
Liver Int
; 43(9): 1879-1889, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37288712
2.
Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.
Clin Diabetes
; 40(3): 327-338, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983425
3.
Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues.
Liver Int
; 41(1): 48-57, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33373114
4.
Liver stiffness measurements by 2-dimensional shear wave elastography compared to histological and ultrasound parameters in primary biliary cholangitis.
Scand J Gastroenterol
; 56(10): 1187-1193, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34375562
5.
Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis.
Hepatology
; 67(1): 260-272, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28370257
6.
Prognostic Models for Survival in Patients with Stable Cirrhosis: A Multicenter Cohort Study.
Dig Dis Sci
; 62(5): 1363-1372, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28251503
7.
Changes of HBsAg and interferon-inducible protein 10 serum levels in naive HBeAg-negative chronic hepatitis B patients under 4-year entecavir therapy.
J Hepatol
; 60(1): 62-8, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-24012614
8.
Prevalence and clinical course of hepatitis delta infection in Greece: a 13-year prospective study.
J Hepatol
; 59(5): 949-56, 2013 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-23850875
9.
Ultrasensitive amplification refractory mutation system real-time PCR (ARMS RT-PCR) assay for detection of minority hepatitis B virus-resistant strains in the era of personalized medicine.
J Clin Microbiol
; 51(9): 2893-900, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23804383
10.
Virological suppression does not prevent the development of hepatocellular carcinoma in HBeAg-negative chronic hepatitis B patients with cirrhosis receiving oral antiviral(s) starting with lamivudine monotherapy: results of the nationwide HEPNET. Greece cohort study.
Gut
; 60(8): 1109-16, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21270118
11.
PNPLA3 rs 738409 and Other Nongenetic Factors Associated with Hepatic Steatosis Estimated by Magnetic Resonance Imaging Proton Density Fat Fraction in Adult Greek Subjects with Type 2 Diabetes Mellitus.
Metab Syndr Relat Disord
; 20(2): 124-131, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34962148
12.
HERACLIS-TAF: a multi-centre prospective cohort study on 2-year safety and efficacy of tenofovir alafenamide in patients with chronic hepatitis B with renal and/or bone disorders or risks.
Aliment Pharmacol Ther
; 56(4): 702-712, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35736010
13.
Hepatitis B surface antigen: relation to hepatitis B replication parameters in HBeAg-negative chronic hepatitis B.
J Hepatol
; 55(1): 61-8, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21145875
14.
Effect of antiviral therapy on the immunohistochemical expression of bcl-xL and bax protein in patients with HBeAg-negative chronic hepatitis B.
J Med Virol
; 83(7): 1165-71, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21567420
15.
Long-term adefovir plus lamivudine therapy does not decrease creatinine clearance in HBeAg-negative chronic hepatitis B patients.
Liver Int
; 31(10): 1525-32, 2011 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-22093327
16.
Serum apoptotic caspase activity in chronic hepatitis C and nonalcoholic Fatty liver disease.
J Clin Gastroenterol
; 44(4): e87-95, 2010 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-19881359
17.
Is there a meaningful serum hepatitis B virus DNA cutoff level for therapeutic decisions in hepatitis B e antigen-negative chronic hepatitis B virus infection?
Hepatology
; 48(5): 1451-9, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18924246
18.
Circulating and liver tissue levels of retinol-binding protein-4 in non-alcoholic fatty liver disease.
Hepatol Res
; 39(10): 972-8, 2009 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-19624771
19.
Collagen proportionate area is an independent predictor of long-term outcome in patients with non-alcoholic fatty liver disease.
Aliment Pharmacol Ther
; 49(9): 1214-1222, 2019 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30882933
20.
Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
Scand J Gastroenterol
; 43(9): 1128-36, 2008.
Artículo
en Inglés
| MEDLINE | ID: mdl-18609175